Asset Managers Tech analyzes & addresses the policy and advocacy interests of the investment management industry in this COVID – 19 period. As a not for profit trade group, we focus particular attention on the use of modern technology by AMT members along with other industry leaders.
Here are the noteworthy points made by our speakers at our April 15, 2021 AMT Zoom Meeting:
By Dr. Stanley Zaborowski, AMT Medical Adviser:
Regarding the Johnson & Johnson COVID – 19 Vaccine – There should be a pause in offering J & J vaccine for 10 to 14 days. Then the FDA and the CDC can make a decision upon considering the risk of blood clots apparently involving one recipient for each batch of 1,000,000 doses of J & J administered. If the Government ends up pulling back on use of J & J, it is important to note that the U.S. would still be able to achieve “herd immunity” (to the level of 75 to 85% of American residents) based on available supply of the Pfizer and Moderna vaccines.
By Xavier Touret, AMT Industry Practices Adviser:
Regarding Working From Home during the Pandemic – Because WFH has involved extensive reliance on personal technology devices, AMT should consider studying the effects of devices on firms’ corporate internet networks. Other questions for AMT study: what is the effect on a firm’s software resources with the increased use of personal devices & what are the standards during WFH for keeping an inventory of your organization’s IT infrastructure?
AMT welcomes industry input regarding the above noteworthy points developed by our speakers at our 4/15 Zoom meeting. Please CLICK HERE to view a video replay of this meeting. Kindly contact Joe Sack with questions or comments regarding these newly issued noteworthy points.
Stay Safe,
Joe Sack, President, Asset Managers Tech
Mobile: 1-914-648-0088